Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma.

Zhao S, Yuan Q, Hao H, Guo Y, Liu S, Zhang Y, Wang J, Liu H, Wang F, Liu K, Ling EA, Hao A.

J Pathol. 2011 Apr;223(5):672-82. doi: 10.1002/path.2827.

PMID:
21341266
2.

OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an antiapoptotic factor.

Asadi MH, Mowla SJ, Fathi F, Aleyasin A, Asadzadeh J, Atlasi Y.

Int J Cancer. 2011 Jun 1;128(11):2645-52. doi: 10.1002/ijc.25643.

3.

The novel OCT4 spliced variant OCT4B1 can generate three protein isoforms by alternative splicing into OCT4B.

Gao Y, Wang X, Han J, Xiao Z, Chen B, Su G, Dai J.

J Genet Genomics. 2010 Jul;37(7):461-5. doi: 10.1016/S1673-8527(09)60065-5.

PMID:
20659710
4.

A coding-independent function of gene and pseudogene mRNAs regulates tumour biology.

Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP.

Nature. 2010 Jun 24;465(7301):1033-8. doi: 10.1038/nature09144.

5.

Concise review: isoforms of OCT4 contribute to the confusing diversity in stem cell biology.

Wang X, Dai J.

Stem Cells. 2010 May;28(5):885-93. doi: 10.1002/stem.419. Review.

6.

[Identification and characterization of ovarian cancer stem-like cells from primary tumor.].

Lai DM, Liu T, Huang Y, Wang LH, Zhang J, Cheng WW.

Zhonghua Fu Chan Ke Za Zhi. 2009 Dec;44(12):936-40. Chinese.

PMID:
20193423
7.

MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells.

Xu N, Papagiannakopoulos T, Pan G, Thomson JA, Kosik KS.

Cell. 2009 May 15;137(4):647-58. doi: 10.1016/j.cell.2009.02.038.

8.

OCT4B1 isoform: the novel OCT4 alternative spliced variant as a putative marker of stemness.

Papamichos SI, Kotoula V, Tarlatzis BC, Agorastos T, Papazisis K, Lambropoulos AF.

Mol Hum Reprod. 2009 May;15(5):269-70. doi: 10.1093/molehr/gap018.

9.

Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights.

Looijenga LH.

J Pathol. 2009 Jun;218(2):146-62. doi: 10.1002/path.2522. Review.

PMID:
19253916
10.

Oct4A is expressed by a subpopulation of prostate neuroendocrine cells.

Sotomayor P, Godoy A, Smith GJ, Huss WJ.

Prostate. 2009 Mar 1;69(4):401-10. doi: 10.1002/pros.20895.

11.

OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells.

Atlasi Y, Mowla SJ, Ziaee SA, Gokhale PJ, Andrews PW.

Stem Cells. 2008 Dec;26(12):3068-74. doi: 10.1634/stemcells.2008-0530.

12.

Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research.

Liedtke S, Stephan M, Kögler G.

Biol Chem. 2008 Jul;389(7):845-50. doi: 10.1515/BC.2008.098. Review.

PMID:
18627312
13.

Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells.

Chen YC, Hsu HS, Chen YW, Tsai TH, How CK, Wang CY, Hung SC, Chang YL, Tsai ML, Lee YY, Ku HH, Chiou SH.

PLoS One. 2008 Jul 9;3(7):e2637. doi: 10.1371/journal.pone.0002637.

14.

Oct4 and its pseudogenes confuse stem cell research.

Liedtke S, Enczmann J, Waclawczyk S, Wernet P, Kögler G.

Cell Stem Cell. 2007 Oct 11;1(4):364-6. doi: 10.1016/j.stem.2007.09.003. No abstract available. Erratum in: Cell Stem Cell. 2008 Feb;2(2):190.

15.

Differential expression of SOX17 and SOX2 in germ cells and stem cells has biological and clinical implications.

de Jong J, Stoop H, Gillis AJ, van Gurp RJ, van de Geijn GJ, Boer Md, Hersmus R, Saunders PT, Anderson RA, Oosterhuis JW, Looijenga LH.

J Pathol. 2008 May;215(1):21-30. doi: 10.1002/path.2332.

PMID:
18348160
16.

Sequence variation in the human transcription factor gene POU5F1.

Hussain SK, Sequerra R, Bertucci C, Hastings NC, Rieder M, Schwartz SM.

BMC Genet. 2008 Feb 6;9:15. doi: 10.1186/1471-2156-9-15.

17.

Oct4 expression is not required for mouse somatic stem cell self-renewal.

Lengner CJ, Camargo FD, Hochedlinger K, Welstead GG, Zaidi S, Gokhale S, Scholer HR, Tomilin A, Jaenisch R.

Cell Stem Cell. 2007 Oct 11;1(4):403-15.

18.

Further characterization of the first seminoma cell line TCam-2.

de Jong J, Stoop H, Gillis AJ, Hersmus R, van Gurp RJ, van de Geijn GJ, van Drunen E, Beverloo HB, Schneider DT, Sherlock JK, Baeten J, Kitazawa S, van Zoelen EJ, van Roozendaal K, Oosterhuis JW, Looijenga LH.

Genes Chromosomes Cancer. 2008 Mar;47(3):185-96.

PMID:
18050305
19.

Induction of pluripotency: from mouse to human.

Zaehres H, Schöler HR.

Cell. 2007 Nov 30;131(5):834-5.

20.

Absence of OCT4 expression in somatic tumor cell lines.

Cantz T, Key G, Bleidissel M, Gentile L, Han DW, Brenne A, Schöler HR.

Stem Cells. 2008 Mar;26(3):692-7.

Items per page

Supplemental Content

Support Center